Pharma boss warns NHS system for approving recent drugs needs radical reform as many recent treatments are being assessed under outdated criteriaThe British boss of the world’s biggest drug company,Pfizer, has claimed that even cash strapped Greece has more access to recent medicines than the UK.
Erik Nordkamp warned that the system for approving recent drugs in Britain needs radical reform as it could stop a recent wave of specialist and personalised medicines becoming available for patients. “The kind assessment needs radical reform, or Nordkamp said,referring to National Institute for Health and Care Excellence, which decides on which drugs are cost effective for the NHS to buy. “It hasn’t gone with the time, or we use the same methodology that we enjoy used for the final 16 years.”Continue reading...
Source: theguardian.com